Aurora Cannabis Inc. (ACB.TO) (TSE:ACB) had its target price hoisted by CIBC from C$15.00 to C$17.00 in a research report issued to clients and investors on Monday, BayStreet.CA reports. CIBC’s price target suggests a potential downside of 13.92% from the company’s previous close.
A number of other research firms also recently issued reports on ACB. Stifel Nicolaus lowered their target price on Aurora Cannabis Inc. (ACB.TO) from C$10.50 to C$3.60 in a research report on Wednesday, October 28th. ATB Capital raised Aurora Cannabis Inc. (ACB.TO) from an “underperform” rating to a “sector perform” rating in a research report on Tuesday, November 17th. Cowen lifted their target price on Aurora Cannabis Inc. (ACB.TO) from C$10.00 to C$16.00 in a research report on Tuesday, November 10th. Jefferies Financial Group lowered their target price on Aurora Cannabis Inc. (ACB.TO) from C$6.90 to C$4.93 and set an “underperform” rating on the stock in a research report on Monday, November 16th. Finally, Atb Cap Markets raised Aurora Cannabis Inc. (ACB.TO) from an “underperform” rating to a “sector perform” rating in a research report on Monday, November 16th. One research analyst has rated the stock with a sell rating and five have issued a hold rating to the company. The stock has a consensus rating of “Hold” and an average target price of C$10.22.
Shares of Aurora Cannabis Inc. (ACB.TO) stock opened at C$19.75 on Monday. The firm has a market cap of C$3.90 billion and a price-to-earnings ratio of -0.61. The stock’s 50-day moving average is C$13.57 and its 200-day moving average is C$11.13. Aurora Cannabis Inc. has a one year low of C$4.93 and a one year high of C$28.32. The company has a debt-to-equity ratio of 23.54, a current ratio of 1.88 and a quick ratio of 0.98.
Aurora Cannabis Inc. (ACB.TO) (TSE:ACB) last issued its quarterly earnings results on Monday, November 9th. The company reported C($0.86) EPS for the quarter, missing analysts’ consensus estimates of C($0.32) by C($0.54). The firm had revenue of C$67.81 million during the quarter, compared to the consensus estimate of C$64.00 million. On average, equities analysts expect that Aurora Cannabis Inc. will post -0.68 EPS for the current year.
In other news, Senior Officer William Glen Ibbott sold 20,156 shares of the business’s stock in a transaction that occurred on Monday, November 23rd. The stock was sold at an average price of C$9.43, for a total transaction of C$190,071.08. Following the completion of the sale, the insider now owns 2,728 shares in the company, valued at C$25,725.04.
Aurora Cannabis Inc. (ACB.TO) Company Profile
Aurora Cannabis Inc produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Further Reading: How does a reverse stock split work?
Receive News & Ratings for Aurora Cannabis Inc. (ACB.TO) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis Inc. (ACB.TO) and related companies with MarketBeat.com's FREE daily email newsletter.